HealthcareAscendis raised to outperform by Oppenheimer ahead of drug launchBy Helitra.com·September 8, 2024·1 min read Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: SeekingalphaADVERTISEMENT ADVERTISEMENTahead Ascendis drug launch Oppenheimer outperform raised Post navigation Previous storyVor Bio stock rallies post-market on trem-cel study dataNext storyLisata jumps on FDA orphan drug status for bile duct cancer drug
Fitness · HealthcareStop Worrying About Fasted Cardio: Your Total Daily Intake Matters More for Fat LossOctober 25, 2026Fasted training has become a near-religious topic. Burn more fat, trigger autophagy, unlock longevity, flip some ancient metabolic switch. Although some of that…
Fitness · HealthcareMenopause May Be More of a Sudden Switch Than a Slow Fade, Huge Study FindsOctober 25, 2026Hot flashes may be the most familiar sign of menopause, but they are hardly the whole story. A huge new analysis suggests the…
Fitness · HealthcareThe Longer You Sit, The More This Muscle Activity FadesOctober 25, 2026One email turns into ten, meetings run back-to-back, and suddenly you’ve spent hours in your chair. You might notice a stiff back, but…